XTalks

NOVEMBER 16, 2020

Moderna announced today that its highly anticipated COVID-19 vaccine candidate appears to be 94.5 The news comes shortly after Pfizer and BioNTech’s mega announcement last week of their COVID-19 vaccine having shown 90 percent efficacy in an ongoing large-scale Phase III trial. The vaccine is given in two doses.

Vaccination 105

Vaccination Vaccine Trials Allergies 105

Pharmaceutical Technology

JUNE 9, 2023

The drug performed “extraordinarily well” in a variety of cohorts, said Nimish Patel, PharmD, professor of clinical pharmacy at University of California San Diego. After a long period without any new approvals, in May, the FDA approved GSK’s vaccine Arexvy for the prevention of LRTD caused by RSV in individuals 60 and older.

FDA Approval 147

FDA Approval Antibody Allergies Packaging 147

The Pharma Data

JANUARY 25, 2021

Severe Allergic Reactions to Moderna COVID-19 Vaccine Rare: CDC. Only 10 people in the entire United States have had severe allergic reactions to Moderna’s COVID-19 vaccine, out of more than 4 million who’ve received the first dose, a new government report shows. minutes after vaccination. In December, U.S.

Allergies 52

Allergies Vaccination Vaccine Containment 52

The Pharma Data

MAY 27, 2022

Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with certain allergies or critical health conditions. This type of specialized medical infant formula is currently in short supply in the U.S. “We

Production 52

Production Manufacturing Pharmacy Cosmetics 52

The Pharma Data

MAY 14, 2021

You go to extreme trouble to remove all the possible allergens in your life — from perfumes to favorite foods — You do confusing & inconclusive allergy testing, yet nothing improves your hives. Let’s see a pharmacy or doctor top that! Let’s see a pharmacy or doctor top that! Let’s see a pharmacy or doctor top that!

Doctors 52

Doctors Doctor Production Pharmacy 52

XTalks

MARCH 1, 2021

Dr. Hom says that for prescription medications in general, there has been a lower incidence of use simply due to the fact that people are avoiding trips to the pharmacy during the pandemic. But if you thought the growing number of patients presenting with mask-associated dry eye would mean higher sales for Restasis, think again.

Sales 119

Sales Drugs Life Science Containment 119

The Pharma Data

JULY 29, 2021

Essential safety information on the authorized emergency use of baricitinib includes warnings related to serious infections, thrombosis, abnormal laboratory values, vaccinations and hypersensitivity. Under the EUA, inpatient pharmacies in the U.S. Vaccinations: Avoid use of live vaccines with baricitinib.

HR 52

HR Licensing Licensing FDA Approval 52